Suvoda Announces General Availability of New eCOA Solution
New solution delivers simplified questionnaire licensing and localizations, streamlined device logistics, and improved data integrity.
Suvoda has announced the general availability of its electronic clinical outcome assessments (eCOA) product that delivers simplified questionnaire licensing and localizations, streamlined device logistics, and improved data integrity. Click to tweet.
Suvoda eCOA is delivered on a single platform with Suvoda IRT and eConsent, and is designed to work with these products to help clinical trial sponsors and sites manage complex clinical trials and focus more time on patient interactions.
Reference
Suvoda Announces General Availability of Powerful New eCOA Solution. (2023, May 23). Cision PR Newswire.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
